Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis

The body of evidence showing a lesser impact of immunoglobulin G (IgG)values on outcomes in patients with autoimmune hepatitis (AIH) is growing. However, there is still a lack of robust information on the long-term outcomes, especially in patients who achieve persistent transaminase normalization. Persistently elevated IgG or IgG flares in patients with persistently normal transaminases do not seem to affect outcomes in patients with AIH. These results challenge the current definition of complete biochemical response in patients with AIH. Transaminase level normalization appeared to be the best treatment endpoint.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-08-29
DOI
https://doi.org/10.1016/j.jhepr.2025.101562
Citations
3
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
3.97

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis

Beatriz Muñoz, María Del Barrio, Bastian Engel, Javier Crespo et al.
3 citations
JHEP Reports
Liver Diseases and Immunity
3.97
article

Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis

Beatriz Muñoz, María Del Barrio, Bastian Engel, Javier Crespo, Johannes Hartl, Manuel Rodríguez‐Perálvarez, Ana Barreira‐Díaz, Álvaro Díaz‐González, Richard Taubert, Christoph Schramm, Alberto Gómez, Ignasi Olivas, Sergio Rodríguez‐Tajes, Lorena Carballo‐Folgoso, Mireia Miquel, Ida Schregel, Inmaculada Castelló, Mar Riveiro‐Barciela, Ana Arencibía, Clara Isabel González, Felix Volmer, María‐Carlota Londoño, Montserrat Garcı́a-Retortillo, Diana Paola Bocanegra Horta, Jesús M. González‐Santiago, Magdalena Salcedo, Manuel Hernández‐Guerra, Judith Gómez, Indhira Pérez‐Medrano, Margarita Sala, Carmen Álvarez‐Navascués, Enrique Frisancho-Morales
article en
3 citations

Abstract

The body of evidence showing a lesser impact of immunoglobulin G (IgG)values on outcomes in patients with autoimmune hepatitis (AIH) is growing. However, there is still a lack of robust information on the long-term outcomes, especially in patients who achieve persistent transaminase normalization. Persistently elevated IgG or IgG flares in patients with persistently normal transaminases do not seem to affect outcomes in patients with AIH. These results challenge the current definition of complete biochemical response in patients with AIH. Transaminase level normalization appeared to be the best treatment endpoint.

JHEP ReportsVol. 7(11)
Universität Hamburg (DE), Hospital Universitario de Canarias (ES), Hospital General Universitario Gregorio Marañón (ES), Medizinische Hochschule Hannover (DE), Hospital Universitario Nuestra Señora de Candelaria (ES), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Complejo Hospitalario de Salamanca (ES), Marqués de Valdecilla University Hospital (ES), University Medical Center Hamburg-Eppendorf (DE), Instituto de Investigación Marqués de Valdecilla (ES), Institut d'Investigació Biomèdica de Girona (ES), Hospital Universitario de Burgos (ES), Hospital Universitario Reina Sofía (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Vall d'Hebron Hospital Universitari (ES), Hospital General Universitario De Valencia (ES), Mútua Terrassa (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Parc de Salut (ES), Hospital Universitario Central de Asturias (ES), Instituto de Investigación Biomédica de Salamanca (ES), Institute of Research and Innovation Parc Tauli (ES), ERN GUARD-Heart (NL), Fundació Clínic per a la Recerca Biomèdica (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Ramón y Cajal (ES), ERN RARE-LIVER (DE)
Asociación Española para el Estudio del Hígado, European Commission, Deutsche Forschungsgemeinschaft, Medizinischen Hochschule Hannover, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 5%
Liver Diseases and Immunity
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.